William L. Pridgen's most recent trade in Dogwood Therapeutics Inc. was a trade of 2,917 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 26, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 26 Feb 2024 | 2,917 | 2,917 | - | - | Stock Option (right to buy) | ||
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 21 Aug 2023 | 15,335 | 52,045 | - | 1.3 | 19,992 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | ||
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | ||
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 18 May 2022 | 241 | 36,710 | - | 4.5 | 1,085 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 17 May 2022 | 13,450 | 36,469 | - | 4.4 | 58,914 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 29 Mar 2022 | 600 | 23,019 | - | 4.9 | 2,964 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 23 Mar 2022 | 2,197 | 22,419 | - | 5.5 | 12,002 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 27 Jan 2022 | 4,180 | 18,722 | - | 6.0 | 24,998 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 03 Jan 2022 | 2,215 | 14,542 | - | 5.4 | 12,034 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 21 Dec 2021 | 8,827 | 12,327 | - | 5.7 | 49,997 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 07 Jul 2021 | 942 | 710,734 | - | 6.3 | 5,951 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | ||
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 28 Jan 2021 | 3,500 | 3,500 | - | 7.5 | 26,145 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 28 Jan 2021 | 801 | 0 | - | - | Warrant to Purchase Common Stock | ||
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 28 Jan 2021 | 801 | 727,993 | - | 7.8 | 6,248 | Common Stock | |
| Dogwood Therapeutics Inc. | William L. Pridgen | Director | 17 Dec 2020 | 1,500 | 727,192 | - | 12.0 | 17,970 | Common Stock |